Sign up to save your podcasts
Or
Share ACCEL Lite: ACC.22 Late Breaker: ADAPT-TAVR Trial - Edoxaban Versus DAPT For Valve Thrombosis And Cerebral TE After TAVR
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ACCEL Lite: ACC.22 Late Breaker: ADAPT-TAVR Trial - Edoxaban Versus DAPT For Valve Thrombosis And Cerebral TE After TAVR
What is clinical problem with regard to leaflet thrombosis after TAVR, and what are the main findings of the ADAPT-TAVR trial?
In this interview, Duk-Woo Park, MD and Sun Moon Kim MD, with Zaid I. Almarzooq MBBCh, discuss Late Breaker: Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial.
View all episodes
By American College of Cardiology
3.8
4747 ratings
What is clinical problem with regard to leaflet thrombosis after TAVR, and what are the main findings of the ADAPT-TAVR trial?
In this interview, Duk-Woo Park, MD and Sun Moon Kim MD, with Zaid I. Almarzooq MBBCh, discuss Late Breaker: Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial.
More shows like ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
View all
JAMA Editors' Summary
130 Listeners
NEJM This Week
319 Listeners
JACC Podcast
160 Listeners
This Week in Cardiology
862 Listeners
JAMA Clinical Reviews
494 Listeners
JACC Specialty Journals
21 Listeners
Circulation on the Run
32 Listeners
JAMA Medical News
87 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
135 Listeners
Core IM | Internal Medicine Podcast
1,081 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
186 Listeners
Cardionerds: A Cardiology Podcast
414 Listeners
Mayo Clinic Cardiovascular CME
35 Listeners
Sensible Medicine
136 Listeners